ASH 2023|"Muryar Lu Daopei" tana rera waƙa a dandalin duniya

Al'umman Hematology (Ash) shi ne babban taron ilimi a fagen Hematology a duk duniya. Kasancewar an zabi asibitin Lu Daopei a matsayin wanda zai zo na karshe a hukumar ta ASH tsawon shekaru a jere yana nuna cikakken nasarorin da ya samu a fannin ilimi sannan kuma ya nuna amincewar da tawagar likitocin Lu Daopei da hukumomin duniya suka yi a fannin ilmin jini. A nan gaba, za mu ci gaba da yin bincike da ƙirƙirar mafi aminci kuma mafi inganci hanyoyin bincike da hanyoyin warkewa don samun ingantattun magunguna na asibiti da kuma rayuwa na dogon lokaci ga yawancin marasa lafiya na haematological!

An gudanar da taron shekara-shekara karo na 65 na kungiyar hadin gwiwar jini ta Amurka (ASH) a birnin San Diego na kasar Amurka daga ranar 9 zuwa 12 ga watan Disamba, 2023. A matsayin taron shekara-shekara mafi girma kuma mafi tasiri a fannin ilmin jini na duniya, Majalisar ASH ta dauki nauyin dubun dubatar mutane. ƙwararrun masana ilimin jini da likitoci daga ko'ina cikin duniya kowace shekara. Rahotanni na ilimi da aka gabatar suna wakiltar mafi mahimmancin sakamakon bincike da yanke shawara a fannin ilimin jini.

Dean Lu Peihua, shugaban ilimi na asibitin Lu Daopei, ya jagoranci tawagar zuwa wurin taron don yin musayar, koyo da kuma rabawa tare da masana ilimin jini da masana daga ko'ina cikin duniya ta hanyar rahoton baka 1 da kuma nunin jaridu na bango 9.

Chimeric Antigen Receptor (CAR) -T Cell Therapy for Refractory/Relapsed Acute Myeloid leukemia: Phase I Clinical Trial" da Dean Lu Peihua ya ruwaito ta baki ya sami kulawa sosai.

Dean Lu Peihua ya ambata a cikin rahoton cewa sakamakon binciken ya nuna mahimmancin inganci da amincin CD7 CAR-T (NS7CAR-T). Ko da yake an iyakance shi da girman samfurin, babu shakka za a sami ƙarin bayanai ta hanyar ƙarin ƙungiyoyin haƙuri da tsawon lokaci na bin diddigin ƙarin tabbaci, amma waɗannan kuma suna ba wa asibitin babban bege da tabbaci.

Yana da kyau a faɗi cewa, a matsayin ƙungiyar farko ta shiga cikin layi tun bayan barkewar cutar, akwai likitocin matasa da yawa a cikin ƙungiyar da ke halartar taron a Amurka. Kungiyar Likitoci ta Lu Daopei ta ba da himma sosai wajen horar da likitocin matasa, kuma sun cika abin da ake tsammani. Daga cikin sakamakon bincike guda 10 da kungiyar ta zaba a wannan taron shekara-shekara, 5 matasa da matsakaitan likitocin kungiyar ne suka rubuta.

Domin ci gaba da inganta matakin gano cutar da kuma kula da ciwace-ciwacen jini da kuma kawo sabon fata ga karin majinyata, tawagar likitocin Lu Daopei sun haskaka sosai kan matakan ilimi da dama a gida da waje. Tun daga 2018, ƙungiyar ta ba da rahoton sakamakon bincike fiye da sau 150 a taron hematological na duniya kuma an buga fiye da takardun ilimi na 300. Kowace shekara, ana iya ganin ƙungiyar Lu DaoPei a manyan abubuwan da suka shafi ilimin jini na duniya kamar ASH, EHA, EBMT, JSH, da dai sauransu.

Ya zuwa karshen watan Disamba na shekarar 2022, kungiyar Likitoci ta Lu Daopei ta kammala jimillar dashen kwayar cutar hematopoietic guda 7852, daga cikinsu 5597 sun kasance dashen dashen hanji, wanda ya kai kashi 71.9% na adadin dashen. Wadannan nasarori masu ban mamaki a cikin masana'antu sun amfana daga ci gaba da bincike na ƙungiyar, wanda ya kafa tasiri mai karfi da kuma kyakkyawan suna a cikin masana'antu da ƙungiyoyi masu haƙuri.